High‑Cost Generic Drugs: A Pharmacy Oxymoron—and Other Emerging Medication Trends
In the pharmacy benefit world, tomorrow’s clinical solutions are often informed by yesterday’s claim data. By closely analyzing pharmacy and claim data, MyMatrixx uncovers emerging medication trends, safety risks, and cost drivers impacting workers’ compensation programs.
In this WorkComp Wire Partner Post, MyMatrixx expert, Courtney Deck, RPh, Senior Manager, Clinical Account Executives, reviews several key medication trends—some familiar and others newly emerging. From rising high‑cost generics and physician‑dispensed medications to increased use of topicals, migraine therapies, and GLP‑1s, advanced analytics reveal where utilization patterns create unnecessary risk and spend—while also highlighting continued progress in reducing opioid use. These insights enable targeted, evidence‑based interventions that protect injured workers without compromising care.